Barinthus Biotherapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BRNS and other ETFs, options, and stocks.About BRNS
Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs.
CEOWilliam Enright
CEOWilliam Enright
Employees105
Employees105
HeadquartersDidcot, Oxfordshire
HeadquartersDidcot, Oxfordshire
Founded2021
Founded2021
Employees105
Employees105
BRNS Key Statistics
Market cap43.57M
Market cap43.57M
Price-Earnings ratio-0.67
Price-Earnings ratio-0.67
Dividend yield—
Dividend yield—
Average volume78.46K
Average volume78.46K
High today$1.10
High today$1.10
Low today$1.00
Low today$1.00
Open price$1.03
Open price$1.03
Volume24.91K
Volume24.91K
52 Week high$2.14
52 Week high$2.14
52 Week low$0.64
52 Week low$0.64